Your session is about to expire
← Back to Search
Behavioural Intervention
Multisensory Rehabilitation for Hemianopia
N/A
Recruiting
Led By Benjamin Rowland, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to perform the visual discriminations in their intact field
Diagnosis of a stable homonymous hemianopia (>6 months) with absence of hemineglect
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights
Study Summary
This trial will test a new rehabilitation paradigm to see if it can improve the lives of those with hemianopia, a condition where someone can only see half of what's in front of them.
Who is the study for?
This trial is for adults under 85 years old with a stable condition called hemianopia, where half of the visual field is lost. Participants should not have attention deficits related to vision (hemineglect) and must be able to see well enough in their unaffected field to do certain visual tasks.Check my eligibility
What is being tested?
The study tests a new way to help people with hemianopia, which involves using multiple senses in therapy. The goal is to show that this approach can improve vision problems caused by damage to the primary visual cortex while leaving other brain areas intact.See study design
What are the potential side effects?
Since this trial focuses on rehabilitation through sensory exercises rather than medication or surgery, side effects are likely minimal but may include fatigue or frustration during training sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can see clearly with my unaffected eye.
Select...
I have had stable partial vision loss for over 6 months without ignoring one side.
Select...
My brain lesion affects my vision but not my touch or spatial awareness.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distance between perceived and actual stimulus location
Humphrey visual field test
Low-vision visual functioning questionnaire (LV-VFQ-48)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Unilaterally blind Subjects will be exposed to visual-auditory stimulationExperimental Treatment1 Intervention
The over-arching objective is to evaluate the functional recovery of vision in hemianopic patients engaged with a multisensory training paradigm. Unilaterally blind participants will participate in weekly training sessions in which they are exposed to high-density spatiotemporally congruent and consistent visual-auditory stimulation. The participants will be tested on a battery of visual tasks probing different levels of function in different environments in a longitudinal study to track recovery.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,242 Previous Clinical Trials
1,004,480 Total Patients Enrolled
Neuroscience Clinical Trial and Innovation Center (NCTIC)UNKNOWN
Benjamin Rowland, PhDPrincipal InvestigatorWake Forest Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 85 years old.I cannot see differences in shapes or colors correctly.I am willing to join the three-month program.I am under 85 years old.I can see clearly with my unaffected eye.I have had stable partial vision loss for over 6 months without ignoring one side.My brain lesion affects my vision but not my touch or spatial awareness.
Research Study Groups:
This trial has the following groups:- Group 1: Unilaterally blind Subjects will be exposed to visual-auditory stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What portion of applicants met pre-screening criteria?
Did not meet criteria
Why did patients apply to this trial?
I’ve tried various orthoptist sessions with minimal progress on my vision field since my stroke 18 mths ago.
PatientReceived 1 prior treatment
Share this study with friends
Copy Link
Messenger